Welcome to our integrative postdoctoral training program in Cancer Chemical Biology and Metabolism (CCBM). Our 34 mentors span four Dana-Farber Cancer Institute departments (Cancer Biology, Cancer Immunology and Virology, Pediatric Oncology, Medical Oncology) to combine two synergistic and conceptually related research disciplines grounded in small molecule chemistry and biochemistry that are of growing importance for both basic and translational research.

The goals of this program are:
1) Provide training in a range of topics relevant to cancer chemical biology and metabolism such as preclinical cancer target validation, chemical screens, structure-based drug discovery, tumor metabolism, cross-talk between tumor and host metabolism, cellular bioenergetics and metabolomics, mechanistic biochemistry, proteomics and chemoproteomics, and animal tumor modelling.

2) Familiarize trainees with state-of-the-art technologies and approaches in chemical biology and metabolic science.

3) Train fellows to identify important questions and approaches that will move the field forward and provide translational opportunities to impact cancer treatment.

4) Provide trainees with opportunities to develop and enhance their grantsmanship and scientific communication skills.

5) Coach fellows on their paths to an independent career in science by implementing Individual Development Plans (IDPs), individual postdoctoral mentoring committees, and customized opportunities for trainees to acquire experience in mentoring, teaching depending on their career goals.

Our mentoring philosophy revolves around the idea that mentoring is a two-way relationship between a mentor and a mentee united in their commitment to achieve shared scientific and professional development goals with mutual respect, and to foster trust and effective feedback. Read the full Mentoring Philosophy statement here.

View leadership here.

The research conducted at Dana-Farber/Harvard Cancer Center has led to the development of life-saving oncology therapeutics, such as Gleevec, Iressa, Herceptin and Avastin.

We are committed to increasing the diversity of the biomedical work force. Women, members of underrepresented minority groups, people with disabilities and veterans are strongly encouraged to apply.

Please view our Applicants page to learn about eligibility and how to apply.

Contact us at:  CCBM Administrator. Use Subject Title: “Info Request: CCBM.”